(Q33947329)

30 July 2017

title

Zoledronic acid inhibits vasculogenic mimicry in murine osteosarcoma cell line in vitro (English)

1 reference

30 July 2017

1 reference

1 reference

Dehao Fu

1

1 reference

30 July 2017

Xianfeng He

2

1 reference

30 July 2017

Shuhua Yang

3

1 reference

30 July 2017

Weihua Xu

4

1 reference

30 July 2017

Tao Lin

5

1 reference

30 July 2017

Xiaobo Feng

6

1 reference

30 July 2017

publication date

30 June 2011

1 reference

BMC Musculoskeletal Disorders

30 July 2017

published in

1 reference

30 July 2017

volume

12

1 reference

30 July 2017

page(s)

146

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2474-12-146

30 July 2017

exact match

0 references

cites work

Anticancer properties of zoledronic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136422

A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136422

Signalling pathways in vasculogenic mimicry

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136422

Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136422

Zoledronic acid : a review of its use in the management of bone metastases of malignancy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136422

Zoledronate has an antitumor effect and induces actin rearrangement in dexamethasone-resistant myeloma cells.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136422

Zoledronic acid - a multiplicity of anti-cancer action

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136422

Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136422

New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136422

Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136422

Investigation of vasculogenic mimicry in sebaceous carcinoma of the eyelid.

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2474-12-146

Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2474-12-146

Practical application of angiogenesis and vasculogenic mimicry in prostatic adenocarcinoma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21718535

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/21718535

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2474-12-146

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference